Randomized Trialhigh evidence

Intravenous Patient-Controlled Analgesia Versus Oral Opioids to Maintain Analgesia for Severe Cancer Pain: A Randomized Phase III Trial.

Journal of the National Comprehensive Cancer Network : JNCCN·May 12, 2026·PMID 42119607

Why it matters

Severe cancer pain often requires rapid, effective titration. This trial validates that IV PCA hydromorphone offers superior analgesia to oral morphine and that a simpler bolus-only regimen can match continuous infusion efficacy with less opioid exposure, informing safer, effective inpatient protocols.

Infographic summary of Intravenous Patient-Controlled Analgesia Versus Oral Opioids to Maintain Analgesia for Severe Cancer Pain: A Randomized Phase III Trial.
Visual abstract · MedLit

The papers that matter, first.

MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.

§

MedLit · Evidence, Distilled